Although the mechanism by which Th17 cells cause tumor regression is not fully understood, one study has shown that Th17 cells drove antitumor immune responses by recruiting immune cells into tumors, activating CD8+ effector T cells, or by directly converting Th17 cells to a Th1 phenotype and producing IFN-γ [19]. This evidence concerns the gene CD8A and neoplasm.